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Edited by Christian GriesingerAbstract The erythrocytic stages of the malaria parasite de-
pend on anaerobic glycolysis for energy. Using [2-13C]glucose
and nuclear magnetic resonance, the glucose utilization rate
and 2,3-diphosphoglycerate (2,3-DPG) level produced in normal
RBCs and Plasmodium falciparum infected red blood cell popu-
lations (IRBCs, with <4% parasite infected red cells), were mea-
sured. The glucose ﬂux in IRBCs was several-folds greater, was
proportional to parasitemia, and maximal at trophozoite stage.
The 2,3-DPG levels were disproportionately lower in IRBCs,
indicating a downregulation of 2,3-DPG ﬂux in non-parasitized
RBCs. This may be due to lowered pH leading to selective diﬀer-
ential inhibition of the regulatory glycolytic enzyme phospho-
fructokinase. This downregulation of the glucose utilization
rate in the majority (>96%) of uninfected RBCs in an IRBC
population may have physiological implications in malaria pa-
tients.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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falciparum1. Introduction
Plasmodium falciparum, the causative agent of malaria,
infects about 5% of worlds population and kills about 2 mil-
lion children every year. The intraerythrocytic stages of the
parasites in humans lead to the clinical manifestations of the
disease. Hypoglycemia and lactic acidosis are often associated
with severe malaria, and one of the reasons for hyperlactat-
emia or acidosis is assumed to be the increased anaerobic gly-
colysis by the infected erythrocytes [1]. Plasmodium parasites
are believed to lack a functional Krebs (TCA) cycle during
the intraerythrocytic growth phase, and therefore the malarial
parasite relies mainly on glycolysis for its energy requirementsAbbreviations: nRBCs, normal red blood cells; IRBCs, infected red
blood cell populations; PRBCs, parasitized red blood cells; uRBC,
uninfected red blood cells of IRBC population; 2,3-DPG, 2,3-diphos-
phoglycerate; CM, conditioned culture medium; PBS, phosphate
buﬀer saline; PGK, phosphoglycerate kinase; PFK, phosphofructoki-
nase; PK, pyruvate kinase; NAD, nicotinamide adenine dinucleotide;
RPMI medium, Roswell Park Memorial Institute medium
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doi:10.1016/j.febslet.2005.09.088[2]. The parasite-infected red blood cells (PRBCs) utilize glu-
cose at a rate higher than that of the normal red blood cells
(nRBCs) [3–6]. Activation of several enzymes of the glycolytic
pathway has been observed in the infected red blood cell pop-
ulation (IRBC), although whether the enhancement in activi-
ties is due to the activation of host or parasite enzymes, or
both, is not clear [5]. These studies were performed with either
parasite-enriched population (10–60)% PRBCs, or >95%
PRBCs (isolated by diﬀerential centrifugation), or with RBC-
free parasites. The emphasis of these studies was to assess
the glucose utilization capabilities of the parasite or parasite-
infected red cells.
In a patient with uncomplicated malaria, the percent of
PRBCs does not normally exceed 3–4%, and is generally
around 0.1–1% (4000–40000/ll) [7]. Is there any inﬂuence of
the small, albeit clinically signiﬁcant, fraction of PRBCs on
the glucose utilization of the vast majority of uninfected RBCs
(uRBCs) surrounding the PRBCs? We have attempted to ad-
dress this question by studying the metabolites produced by
a red cell population containing 0.5–4% PRBC using NMR
spectroscopy. In this report, we present observations which
demonstrate the remarkable ability of a small PRBC cohort
to down-modulate glucose utilization in the majority of
uRBCs.2. Materials and methods
2.1. Chemicals
HEPES, hypoxanthine, sorbitol, lactic acid, saponin, Triton X-100,
pepstatin, leupeptin, PMSF, NADH, ATP and phosphoenolpyruvate
were purchased from Sigma Chemical Company, USA. Albumax
and Roswell Park Memorial Institute medium (RPMI) 1640 was from
GIBCO and [2-13C]glucose was obtained from Isotech Inc., USA.
Other chemicals were of analytical grade and were used as supplied.
2.2. Red cells
Human blood was collected from 25 to 27-year-old healthy individ-
uals with A+ blood group in ACD (38 mM citric acid, 75 mM sodium
citrate, and 136 mM glucose) as the anticoagulant. The erythrocytes
were pelleted, buﬀy coat was discarded to remove the leukocytes,
and washed thrice with RPMI (RPMI 1640 supplemented with
27 mM NaHCO3, 25 mM HEPES, and 0.35 mM hypoxanthine). The
RBCs were then resuspended in complete RPMI (RPMI with 0.5%
albumax). Asexual stages of P. falciparum (3D7 strain) were cultured
in vitro and synchronized by sorbitol treatment as described earlier
[8]. Brieﬂy, the cells were harvested at a stage with predominant rings,
washed and treated with 5% sorbitol (in double distilled water) at
37 C for 10 min, washed repeatedly with RPMI, and subcultured with
RBCs prepared as described above. Parasites were maintained at 5%
hematocrit in complete RPMI at 37 C in a humidiﬁed chamberation of European Biochemical Societies.
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and resuspended at 50–70% hematocrit in D2O containing complete
RPMI and used for NMR spectroscopy. The experiments were started
by adding solid [2-13C]glucose (Isotech Inc.) to 11 mM ﬁnal concentra-
tion.
2.3. Various treatments of the RBCs
For obtaining the conditioned culture medium (CM) the parasite
cultures were synchronized, subcultured with fresh RBCs at a ﬁnal
concentration of 0.5–4% PRBC and incubated at standard culture con-
ditions for 17–20 h. Supernatant from such cultures, ﬁltered through a
0.22 lm ﬁlter, was used as the CM at a ﬁnal concentration of 25% v/v
in the NMR tube. For checking the eﬀect of lactate accumulation on
the RBC metabolism, lactate was added to the RBCs at ﬁnal concen-
trations of 10–40 mM, and the pH was adjusted to 7.4. The eﬀect of
pH was monitored by adjusting the initial pH of the RBC suspension
to 7.4, 7.0 or 6.8. To check the combined eﬀect of lactate and pH,
20 mM lactate was added to the RBC suspension, after which the
pH was adjusted to 7.4, 7.0 or 6.8.
2.4. NMR experiments
13C NMR spectra on the RBCs were recorded at 125.78 MHz on a
Bruker AVANCE AV500 NMR spectrometer. The acquisition param-
eters were 225 ppm spectral width, excitation pulse of 30 (5 ls), with a
1.2 s delay between pulses. The transients (408 or 1280) were stored in
8192 data points resulting in acquisition time of 0.15 s and a digital res-
olution of 3.4 Hz/point. Gated decoupling of the protons was achieved
by applying a power of 18 dB only during acquisition to minimize the
Nuclear Overhauser Eﬀect from the connected protons. The time do-
main spectra were subjected to exponential multiplication leading to
an additional line broadening of 5 Hz before Fourier transformation.
Chemical shifts are in ppm with respect to sodium 3-trimethylsilyl pro-
pionate, which served as an external reference. For quantiﬁcation, inte-
grals of the various resonances were determined using the Bruker
software and corrected as reported earlier [9]. Glucose utilization
and the level of 2,3-diphosphoglycerate (2,3-DPG) were determined
essentially by the method reported for human RBCs [10].
2.5. Preparation of cell lysates and enzyme activity assays
For preparing P. falciparum lysates for the enzyme assays, intracel-
lular parasites were liberated from PRBCs by treatment with 0.15%
saponin [7]. The parasite pellet was washed with phosphate buﬀer sal-
ine (PBS) and solubilized by incubation with 5 vol. of PBS buﬀer con-
taining 1% Triton X-100 and protease inhibitors (pepstatin 1 lg/ml,
leupeptin 1 lg/ml and PMSF 50 lg/ml) on ice for 1 h. The supernatant
fraction was used for the enzyme assays. RBC lysates were prepared by
a modiﬁcation of the method described by Beutler [11]. The enzyme
activities in the cell lysates was followed spectrophotometrically as
the oxidation of NADH to nicotinamide adenine dinucleotide
(NAD), by linking it to the formation of various products in the pres-
ence of an excess of auxiliary enzymes [11]. The pH of the assay mix-
ture was adjusted with HCl to the appropriate value within the range
6.8–7.4. After adding the cell lysate (20 ll), the 0.5 ml mixture was
incubated at 37 C and the reaction was started by adding 2 mM
ATP for phosphofructokinase, and 5 mM PEP for pyruvate kinase.
The decrease of NADH was measured at 340 nm for 5 min with a Per-
kin–Elmer spectrophotometer and the slopes of the curves were deter-
mined.3. Results
13C NMR spectra were recorded for IRBC under culture
conditions similar to that of patients with uncomplicated ma-
laria. Assay mixtures contained human red cell populations in-
fected with P. falciparum at 0.5–4% parasitemia, 70%
hematocrit, pH 7.4, 37 C in the presence of 10–12 mM glu-
cose. The quantitative estimates of metabolites and ﬂux routed
through various intermediates (Fig. 1A) of [2-13C]glucose were
determined as described in Section 2. The IRBC cultures con-
sisted mainly of trophozoites (about 17–20 h post-synchroniza-tion), unless otherwise stated. A typical NMR data proﬁle is
shown for the utilization of [2-13C]glucose for nRBC and
IRBC (2.3% parasitemia) (Fig. 1B and C), and the data are
plotted to show the rates of utilization of glucose, and produc-
tion of [2-13C]lactate (Fig. 1D and E). The rate of glucose uti-
lization of the IRBC was found to be signiﬁcantly higher as
compared to that of nRBCs. With [2-13C]glucose as substrate
[2-13C]lactate originates through glycolysis, while a routing
of the substrate through pentose phosphate pathway results
in the formation of [1-13C]fructose-1,6-bisphosphate and in
turn to [3-13C]lactate. The [2-13C]-2,3-DPG signal was clear
and could be observed distinctly (Fig. 1B and C). The accumu-
lation of 2,3-DPG results in a saturating curve after about
60 min of glucose utilization [10]. Despite the very small num-
ber of parasitized cells (2.3%) in the IRBC, the steady state le-
vel of 2,3-DPG production was decreased to 42% that of
nRBC (Fig. 1D and E).
Table 1 shows the values of glucose utilization and the com-
parative reduction in the steady state levels of 2,3-DPG (d s2,3-
DPG) in IRBC over several experiments. A large variability
was noted in the rate of glucose utilization of red cells obtained
from diﬀerent persons (Table 1). Such a diﬀerence may have to
do with diﬀerent genetic and metabolic states of volunteers
from whom the blood samples were collected. Therefore, in or-
der to be able to compare diﬀerent sets of measurements,
paired uninfected and infected cell measurements were re-
corded using the same source of the blood. The nRBCs were
also incubated under conditions identical to the infected red
blood cell populations (IRBCs), and the diﬀerence was only
in the absence or presence of the <4% of PRBCs. The same
number of cells (109) for IRBCs and nRBCs were used for
NMR measurements. The increase in glucose utilization was
directly proportional to the percent parasitemia of IRBC (Ta-
ble 1), and was consistent with rates observed earlier for P. fal-
ciparum IRBC determined through other methods [4]. The d
s2,3-DPG values decreased as the parasitemia increased (Table
1). In about 1% parasite infected cells, the reduction in the level
of 2,3-DPG was about 30%, while in a 4% culture the reduc-
tion was observed to be 70%.
The glucose ﬂux clearly depended on the sub-stage of the
PRBCs in the IRBC population (Fig. 2). The glucose utiliza-
tion was only marginally higher 2 h after synchronization,
and the maximum rate of utilization was observed for the tro-
phozoite stage, at about 24 h post-synchronization. The levels
of 2,3-DPG decreased with the development of the parasite
(Fig. 2B, II), and in the 24 and 34 h post-synchronization cul-
tures, the 2,3-DPG could not be detected at all. Thus, over sev-
eral experiments it was observed that the steady state levels of
2,3-DPG were lowered signiﬁcantly in IRBC.
The lowering of 2,3-DPG levels in IRBC could be caused by
speciﬁc regulation of 2,3-DPG intermediate, as also by the
inhibition of glucose utilization in the uRBCs due to the pres-
ence of PRBCs. To assess whether the secretions from PRBCs
were involved in such inhibition, the eﬀect of conditioned cul-
ture supernatant medium (CM) of IRBC on the glucose utili-
zation of nRBCs was examined (Fig. 3, Table 2). The
inhibition in glucose utilization rate was signiﬁcant and ranged
from 23% to 81%, suggesting that the inhibition is not speciﬁc
for the 2,3-DPG intermediate, but occurs at the level of glucose
utilization as well. The CM from nRBCs did not show any sig-
niﬁcant inhibition (Table 2). Increasing glucose concentrations
in the medium compensated for this inhibition in the 2,3-DPG
  
 
Fig. 1. Utilization of [2-13C]glucose by human RBCs infected with malarial parasite P. falciparum. Pathway of glucose utilization (A); Stacked plot
of the time-lapse 13C NMR spectra of nRBC (B) and IRBC (C) after incubation with [2-13C]glucose – each spectrum represents 1280 scans acquired
in 30 min; Concentration proﬁles of C2-glucose, C2-lactate and C2-2,3-DPG of the RBC (D) and IRBC (E). 13C NMR spectra were recorded and the
data processed as mentioned in Section 2. The lines are linear ﬁts for C2-glucose and C2-lactate. C2-2,3-DPG data is ﬁtted to the proﬁle as mentioned
in [13].
Table 1
Glucose ﬂux and 2,3-DPG levels in human red blood cells
Exp no. Cells (% parasitaemia) Glucose ﬂux Steady state 2,3-DPG level
lmol/h/ml % of nRBC lmol/ml % of nRBC % of Glu. ﬂux d s-DPG(%)
1 nRBC 0.46 ± 0.02 100 0.34 ± 0.02 100 74
IRBC (1.1) 0.65 ± 0.03 141 0.25 ± 0.06 66 39 34
2 nRBC 1.70 ± 0.57 100 0.35 ± 0.11 100 21
IRBC (0.83) 2.58 ± 0.93 152 0.25 ± 0.10 71 10 29
3 nRBC 0.33 ± 0.02 100 0.26 ± 0.01 100 79
IRBC (2.3) 0.77 ± 0.02 233 0.11 ± 0.01 42 14 58
4 nRBC 2.53 ± 0.36 100 0.64 ± 0.13 100 25
IRBC (4.3) 9.59 ± 0.27 380 0.19 ± 0.14 30 2 70
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Fig. 2. Erythrocyte stage speciﬁc glucose utilization by P. falciparum in two experiments (I and II). Concentration proﬁles for C2-glucose (A) and
C2-2,3-DPG (B) are shown for cultures at I: 2 and 17 h (parasitemia 2.3%); and II: 12, 17, 24 and 34 h (parasitemia 1.6%) post-synchronization,
respectively. Note that in panel IIB no curves are shown for 24 and 34 h, because the 2,3-DPG levels were below detection in these sub-stages of the
parasite.
6154 M. Mehta et al. / FEBS Letters 579 (2005) 6151–6158production (Fig. 3). Addition of 100 mM glucose reversed the
glucose utilization rate as well as d s2,3-DPG in nRBCs treated
with CM (Fig. 3I). In IRBCs as well, an increase in the glucose
concentrations caused an increase in 2,3-DPG production
(Fig. 3II and III). However, the rate of glucose utilization of
IRBCs at these high concentrations of glucose either remained
unaltered (Fig. 3II) or was inhibited (Fig. 3III). The eﬀect of
CM on the merozoite invasion of nRBCs was also evaluated
and no signiﬁcant eﬀect of CM on the eﬃciency of nRBC inva-
sion by merozoites was observed (data not shown).
The parasite cultures from which the CMs were collected are
well buﬀered. Over 20 h with a 4% parasitemia, there was a
maximum decrease in the pH from 7.4 to 7.2. In the NMR
tube, with 70% hematocrit, the buﬀering capacity is low and
after about a 3 h run, the pH drops from 7.4 to 7.0. Assuming
that a local micro-change in pHmay occur under rapid produc-
tion of lactic acid by the infected cells, the glucose utilization
rates of nRBCs at diﬀerent lactate and initial pH conditions
were tested (Fig. 4, Table 2). An increase in initial lactate con-
centration showed no signiﬁcant change in the glucose ﬂux of
RBCs (Fig. 4A). However, the eﬀect of pH change on the glu-
cose utilization of nRBCs is signiﬁcant (Fig. 4B). There did not
appear to be any additional eﬀect of 20 mM lactate over and
above the inhibition caused by the pH change (Fig. 4B). In case
of erythrocytes, dependence of glycolysis on the pH of the med-
ium is well documented [12]. In order to address whether pH
exerted a diﬀerential control on RBC and parasite glycolysis,
we examined the activities of two irreversible enzymes, phos-phofructokinase (PFK) and pyruvate kinase (PK), present in
human RBCs and the parasite, as a function of pH. The activ-
ity of human PFK was observed to reduce by about 80% and
96%, while the reduction in the activity of P. falciparum PFK
was only 10% and 18% with a decrease in pH from 7.4 to 7.2
and 7.0, respectively (Fig. 4C). In contrast, the activity of PK
exhibited no diﬀerential inhibition in the red cells and the par-
asite as a function of pH (Fig. 4D).4. Discussion
The results presented here show that the overall glucose uti-
lization rate of IRBCs increase by about 100-fold, consistent
with earlier observations [4,7]. The actual mechanism(s) of this
high increase in glucose utilization is not understood, and per-
haps reﬂect the properties of the parasite glycolytic enzymes,
and their regulation. Our results also show signiﬁcant down-
modulation in the rate of glucose utilization of the vast major-
ity of uRBCs (>96%) in the presence of a small percentage
(<4%) of P. falciparum infected red cells. This was determined
indirectly through the measurement of the intermediate metab-
olite 2,3-diphosphoglycerate (2,3-DPG), as well as directly by
the addition of spent culture medium of the IRBCs to normal
RBCs. The inhibition of glucose utilization and 2,3-DPG levels
of the uninfected red cells, caused by either the CM or the par-
asite, could be reversed by increasing the glucose concentration
in the medium.
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Fig. 3. Glucose utilization (A) and C2-2,3-DPG production (B) by nRBCs and IRBC under diﬀerent conditions. Experiments show the eﬀect of
conditioned medium (CM) from IRBC at 0.53% parasitemia (I) and 1.6% parasitemia (III). The eﬀect of higher glucose concentrations is shown for
nRBC in the presence of CM (I) and for IRBCs with parasitemia 4.3% (II); and parasitemia 3.8% (III).
Table 2
Glucose ﬂux and 2,3-DPG levels in human red blood cells under various treatments
Exp no. Cells Treatment Glucose ﬂux Steady state 2,3-DPG level
lmol/h/ml % of nRBC lmol/ml % of nRBC % of Glu. ﬂux d s-DPG (%)
1 nRBC – 2.38 ± 0.30 100 1.08 ± 0.41 100
nRBC +CMa (1.3%) 0.44 ± 0.02 19 BDLb –
2 nRBC – 3.83 ± 0.17 100 0.25 ± 0.05 100 6.5
nRBC +CM (0.53%) 1.74 ± 0.34 45 0.10 ± 0.08 40 5.7 60
nRBC +Lactatec 2.77 ± 0.39 72 BDL –
nRBC pH 7.0 2.13 ± 0.13 56 BDL –
nRBC +CM + Glu 5.76 ± 0.66 150 1.81 ± 0.12 724 31
3 nRBC – 1.81 ± 0.23 100 0.38 ± 0.12 100 21
nRBC +CM (0.96%) 0.68 ± 0.11 38 BDL –
nRBC +Lactate 0.89 ± 0.49 49 BDL –
nRBC +CM of UI 1.53 ± 0.21 85 BDL –
aCM, conditioned medium.
bBDL, below detection levels.
c20 mM lactate.
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Fig. 4. Eﬀect of low pH and lactate on glycolysis in nRBCs and P. falciparum. (A) eﬀect of lactate on the glucose ﬂux of nRBCs at pH 7.4; (B) eﬀect
of pH on the glucose ﬂux of nRBCs in the absence or presence of 20 mM lactate. Glucose ﬂux is expressed as % of ﬂux in nRBCs measured at pH 7.4.
(C) Phosphofructokinase (PFK) and (D) Pyruvate Kinase (PK) activity in P. falciparum and nRBC cell extracts at diﬀerent pH values, expressed as %
of activity measured at pH 7.4. The statistical signiﬁcance of the decrease in PFK activity of nRBCs (from that at pH 7.4), was determined by
Students t-test (\P<0.05; \\P<0.001; n>4).
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rum has a single acristate mitochondrion and is devoid of
TCA cycle, relying mainly on anaerobic glycolysis for its
energy requirement [2]. The 13C NMR spectra showed no
resonance(s) corresponding to labeled glutamate carbon(s),
and therefore the signatures of aerobic metabolism were
not observed. The stoichiometric production and accumula-
tion of total lactate conformed to earlier observations that
neither the RBC nor the IRBC possess a functional TCA
cycle.
2,3-DPG is an important metabolite in RBCs. It is mainly
involved in the stabilisation of the deoxy-form of hemoglobin,
thereby facilitating the release of oxygen to the tissues [13]. A
shift in the oxyhemoglobin dissociation curve was reported in
murine malaria infection [14]. Under conditions of sub-opti-
mal oxygen availability, such as at high altitudes or in anemic
persons, the levels of 2,3-DPG increase to facilitate oxygen re-
lease to the tissues [13]. The production of 2,3-DPG, however,
results in less ﬂux through glycolysis, and hence a loss of ATP
generation at the phosphoglycerate kinase (PGK) step
(Fig. 1A). Anaerobic glycolysis yields two ATP molecules
for each glucose molecule consumed. Since each glucose mol-
ecule results in the generation of two ATP molecules at the
PGK step, the 2,3-DPG shunt results in a 100% loss in net
ATP production. In normal RBCs this loss is compensated
by the respiratory gain through the ability of 2,3-DPG to
release oxygen to the tissues. For the malaria parasites, which
rely largely on anaerobic glycolysis, such a loss would besevere. The steady state level of 2,3-DPG is regulated by the
activities of diphosphoglyceromutase (DPGM) and DPG
phosphatase. Unlike the mammalian erythrocytes, P. falcipa-
rum does not appear to possess a separate DPGM speciﬁc for
the production of 2,3-DPG [15]. An impairment of the 2,3-
DPG metabolism of the malarial parasite, have been reported
recently [16]. Moreover, enzymopathic erythrocytes with deﬁ-
cient DPGM did not hamper the parasite growth [17]. There-
fore, it is reasonable to assume that the parasite has no use
for 2,3-DPG and therefore, a lowered level of 2,3-DPG is ex-
pected in PRBCs. However, even assuming that no 2,3-DPG
is produced by PRBCs, the decrease of 2,3-DPG in our exper-
iments, where the PRBCs were <4%, should have been at best
by about 4%. It is this 30% decrease in 2,3-DPG level by 1%
PRBCs, which ﬁrst indicated to us that the vast majority of
uninfected RBCs present in the IRBC sample were not using
glucose in the same way as normal RBCs.
A decrease in the 2,3-DPG level and 2,3-DPG/Hb ratio in
P. knowlesi and P. yoelii infected animals have been ob-
served earlier [3,14]. The decrease in the 2,3-DPG/Hb ratio
was also postulated to be responsible for a shift in the oxy-
haemoglobin dissociation curve [14]. Increase in several gly-
colytic enzyme activities and concomitant reduction in pH
(from 7.2 to 7.0) in freshly collected whole blood from P.
berghei infected mice as compared to uninfected mice have
been reported earlier, although no correlation was proposed
[6]. However, each of the above experiments were performed
with blood containing >40% parasitemia, while our experi-
M. Mehta et al. / FEBS Letters 579 (2005) 6151–6158 6157ments were simulating uncomplicated malaria patients with
<4% parasitemia. In our experiments it was observed that
a decrease in initial pH, but not high lactate concentration,
was an important factor in inhibiting the glucose utilization
rate of nRBCs. We also demonstrate in this paper that the
human red cell PFK, a critical regulatory enzyme for glycol-
ysis, is diﬀerentially inhibited by pH as compared to P. fal-
ciparum PFK, thus providing a mechanism of diﬀerential
rates of glucose utilization in the PRBCs and uRBCs. Exten-
sive in vivo analysis of erythrocyte glycolysis has been car-
ried out using NMR [12,18,19] and, in addition to the
glycolytic ﬂux, the 2,3-DPG synthesizing enzyme is also sig-
niﬁcantly inhibited by low pH [18]. Pyruvate kinase activity
of P. falciparum has been reported [5,20], but the pH depen-
dence has not been documented so far. Our results (Fig. 4)
clearly show that the pH dependent activities of PK from
the red cells and the parasite are not signiﬁcantly diﬀerent.
Activities of PFK enzyme of the murine malaria parasite,
P. berghei, have been reported earlier and a modeling of en-
zyme parameters indicated acid insensitivity of P. berghei
PFK [21,22]. However, no reports exist regarding the prop-
erties of P. falciparum PFK enzyme.
Thus, one of the mechanisms of downregulation of glucose
utilization in uRBCs by PRBCs is likely to be due to the selec-
tive inhibition of uRBC-PFK due to a decrease in pH. How-
ever, other mechanisms also appear to be operative.
Preliminary results in our laboratory show that despite nor-
malization of the pH of the CMs, the inhibition of uRBC-
PFK with CM isolated from IRBC was signiﬁcantly higher
than that of the CM taken from nRBCs. An analysis of the
inhibitory factor(s) present in the CM will help in the elucida-
tion of such mechanisms.
The pathological events that contribute to severe falcipa-
rum malaria are the cerebral syndrome, anemia, hypoxia,
hypoglycemia and lactic acidosis [1,2]. In these assessments,
hypoglycemia is determined by the measurement of the ac-
tual blood glucose levels. Our results suggest a possibility
of functional pseudo-hypoglycemia despite the presence of
substantial glucose levels in the medium. Such pseudo-hypo-
glycemia in malaria patients would result in lower ATP
production in erythrocytes. In addition, the lowering of
2,3-DPG would result in lower oxygen supply to the tissues,
resulting in an overall lethargic state of the patient. A shift
in the oxyhemoglobin dissociation curve has been reported
for the murine malaria infection, although the levels of par-
asitemia in such experiments have been very high (>70%)
[14]. In P. falciparum infections, where parasitemia levels
are generally <4% in peripheral blood, the percent para-
site-infected erythrocytes may be higher at speciﬁc local
points through sequestration or rosetting [23]. In such loca-
tions, the eﬀects of both functional pseudo-hypoglycemia as
well as a shift in the oxyhemoglobin dissociation curve may
be signiﬁcant, and may have serious physiological implica-
tions. Our data shows the release of the inhibition in 2,3-
DPG production and glucose utilization rate of compro-
mised erythrocytes in the presence of higher glucose concen-
trations. The 3–5-fold higher levels of glucose that release
such inhibition are within the limits of glucose tolerance in
normal humans. This suggests the possibility of a better
management of complicated and uncomplicated malaria pa-
tients with frequent intravenous/oral glucose administrations
prescribed along with suitable anti-malarial drugs.Acknowledgements: We thank A. Sehgal, A. Soni and A. Isacc, for
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